Meeting participants presented new, unpublished research results, followed by group discussions in which new ideas were encouraged.
The discovery of how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for glaucoma, diabetic retinopathy, and stroke.
Glaucoma Research Foundation, the nation’s most experienced nonprofit foundation dedicated solely to curing glaucoma and restoring vision through innovative research, recently elected David S. Friedman, MD, PhD, MPH to its Board of Directors.
Kristin Smedley is an award-winning author, TEDx speaker, trailblazer for the disability community, and mother of three children, two of whom were born blind. “Thriving Blind: Succeeding Without Sight” will be the theme of her keynote talk at the Glaucoma Patient Summit in Philadelphia.
Judy and Charles Munnerlyn, PhD, were honored to recognize their extraordinary contributions to improving vision for people around the world.
The prestigious group brings together key industry leaders and members of the corporate community dedicated to glaucoma patient care.
Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, has elected Tracy M. Valorie, BS, MBA to its Board of Directors.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
The free glaucoma audiobook, narrated by Bianca Beach, is available for patients and their families to listen, download, and share.
“This is the largest annual research budget in our 46-year history,” said Thomas M. Brunner, GRF President and CEO.
Attracting nearly 400 participants annually, this unique gathering unites leaders in the field of glaucoma for a full day of informative presentations, stimulating discussions, and valuable networking opportunities.
The Glaucoma 360 Annual Gala will include a reception, a silent art auction featuring artists with vision impairment, and a dinner to celebrate the donors, volunteers, and scientists who do so much to advance Glaucoma Research Foundation’s mission to cure glaucoma and restore vision through innovative research.
“Our goal for this catalyst meeting was to spark some new ideas and approaches to solving neurodegeneration and also to produce a white paper to capture these ideas for future publication,” said Thomas M. Brunner, President and CEO of Glaucoma Research Foundation.
Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the keynote speaker.
Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has selected visually impaired professional triathlete Amy Dixon as keynote speaker for its 2023 Patient Summit, to be held in Long Beach, California, June 23-24.
Shaffer Grants provide seed funds to bold investigators whose creative projects explore promising leads and show strong potential for impact on glaucoma.
The 2023 Shaffer Prize for Innovative Glaucoma Research recognizes two Shaffer Grant recipients whose projects best exemplify the pursuit of breakthrough ideas in the quest to better understand and cure glaucoma.
The New Horizons Forum will take place on February 3rd at San Francisco’s iconic Westin St. Francis Hotel.
GRF's leadership awards will be presented at the Glaucoma 360 Annual Gala on February 2, 2023 at the iconic Westin St. Francis Hotel in San Francisco.
Santen will receive GRF’s highest honor, the Catalyst Award, at the Glaucoma 360 Annual Gala on February 2, 2023, in San Francisco.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right